Newborn Humans Female Male Animals Mice Gray Matter *Premature Birth/drug therapy Acetates/therapeutic use/pharmacology *Quinolines/therapeutic use/pharmacology Disease Models

Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity

Encephalopathy of prematurity (EoP) affects approximately 30% of infants born